No label defined (Q29809)

From lgbtDB
Revision as of 21:30, 7 November 2024 by Superraptor (talk | contribs) (‎Created a new Item)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
No description defined
  • Clinical pharmacology in adolescent transgender medicine.
Language Label Description Also known as
English
No label defined
No description defined
  • Clinical pharmacology in adolescent transgender medicine.

Statements

title
Clinical pharmacology in adolescent transgender medicine. (English)
1 reference
stated in
PubMed
abstract
Adolescent transgender medicine is a growing clinical field. (English)
series ordinal
1
copyright statement
© 2024 The Author(s). British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. (English)
publisher
John Wiley & Sons
on behalf of
British Pharmacological Society
date copyrighted
2024
rights holder
Lauren R. Cirrincione
Kai J. Huang
Gina M. Sequeira
1 reference
stated in
PubMed
Gender-affirming medications for transgender youth may include gonadotropin-releasing hormone (GnRH) agonists, gender-affirming hormones or both. (English)
series ordinal
2
copyright statement
© 2024 The Author(s). British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. (English)
publisher
John Wiley & Sons
on behalf of
British Pharmacological Society
date copyrighted
2024
rights holder
Lauren R. Cirrincione
Kai J. Huang
Gina M. Sequeira
1 reference
stated in
PubMed
To evaluate the potential effects of GnRH agonists (puberty suppression) on pharmacokinetic processes for transgender youth, we searched PubMed from inception to May 2024 for publications on the effects of GnRH agonists on drug absorption, distribution, metabolism or excretion for transgender adolescents or effects on hormones (including gonadotropins, adrenal androgens, sex steroids) that [...] (English)
series ordinal
3
copyright statement
© 2024 The Author(s). British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. (English)
publisher
John Wiley & Sons
on behalf of
British Pharmacological Society
date copyrighted
2024
rights holder
Lauren R. Cirrincione
Kai J. Huang
Gina M. Sequeira
1 reference
stated in
PubMed
No publications discussed the effects of GnRH agonist treatment on pharmacokinetic processes for adolescent transgender people. (English)
series ordinal
4
copyright statement
© 2024 The Author(s). British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. (English)
publisher
John Wiley & Sons
on behalf of
British Pharmacological Society
date copyrighted
2024
rights holder
Lauren R. Cirrincione
Kai J. Huang
Gina M. Sequeira
1 reference
stated in
PubMed
Sixteen publications observed marked decreases in gonadotropins and sex steroids for both adolescent transgender men and adolescent transgender women and slight effects on adrenal androgens. (English)
series ordinal
5
copyright statement
© 2024 The Author(s). British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. (English)
publisher
John Wiley & Sons
on behalf of
British Pharmacological Society
date copyrighted
2024
rights holder
Lauren R. Cirrincione
Kai J. Huang
Gina M. Sequeira
1 reference
stated in
PubMed
During GnRH agonist treatment, changes in body composition and body shape were greater for adolescent transgender people than for cisgender adolescent people. (English)
series ordinal
6
copyright statement
© 2024 The Author(s). British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. (English)
publisher
John Wiley & Sons
on behalf of
British Pharmacological Society
date copyrighted
2024
rights holder
Lauren R. Cirrincione
Kai J. Huang
Gina M. Sequeira
1 reference
stated in
PubMed
Further research is needed to better understand the effects of GnRH agonists on drug metabolism and other pharmacokinetic processes for transgender adolescents receiving GnRH agonists and other gender-affirming medications. (English)
series ordinal
7
copyright statement
© 2024 The Author(s). British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. (English)
publisher
John Wiley & Sons
on behalf of
British Pharmacological Society
date copyrighted
2024
rights holder
Lauren R. Cirrincione
Kai J. Huang
Gina M. Sequeira
1 reference
stated in
PubMed
date published
October 2024
1 reference
stated in
PubMed
date issued
October 2024
1 reference
stated in
PubMed
volume
90
1 reference
stated in
PubMed
issue
10
1 reference
stated in
PubMed
page(s)
2387-2397
1 reference
stated in
PubMed
page start
2387
1 reference
stated in
PubMed
page end
2397
1 reference
stated in
PubMed
 
Retrieved from "https://lgbtdb.wikibase.cloud/w/index.php?title=Item:Q29809&oldid=182003"